dm+d
108974006
Lactation Safety Information
-
Glycoprotein IIb/IIIa inhibitor
No published evidence of safety
Negligible levels anticipated in milk due to the drug’s properties
Negligible absorption from the infant’s gastro-intestinal tract
Although large protein molecules may appear in colostrum, risk to preterm infants and neonates is considered to be small and unproven
Consider suspending breastfeeding during abciximab infusion to minimise any unknown risks
8 November 2021